바이오인

Executive Summary
 
This report establishes that the United Kingdom retains a leading position, in Europe and globally, in the science and commercial translation of regenerative medicine.  The quality of our work, in research and academia, is of a world class, supported by a strict but permissive legislative, and regulatory, framework that is helping innovation to flourish.  The UK is at the forefront of this rapidly evolving technology and is in a good position to take advantage of its promise.